| 000 | 01525cam a2200277 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030816.0 | ||
| 008 | 130331s2010 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aGift | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.34.M.Sc.2010.Sh.S | ||
| 100 | 0 | _aShaimaa Awadain Elsharif | |
| 245 | 1 | 0 |
_aSynthesis of novel diary I heterocycle derivatives and their evaluation as growth inhibitory agents and phosphodiesterase 3 inhibitors / _cShaimaa Awadain Elsharif ; Supervised Ashraf H. Abadi |
| 246 | 1 | 5 | _aتشييد مشتقات جديدة لثنائى ارايل غير متجانس الحلقة وتقيم قدرتهم كمثبطات النمو ومنع نشاط الفوسفوداى استراز 3 |
| 260 |
_aCairo : _bShaimaa Awadain Elsharif , _c2010 |
||
| 300 |
_a90Leaves : _bcharts , facsimiles ; _c30cm |
||
| 502 | _aThesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmaceutical chemistry | ||
| 520 | _aMilrinone is a cyanopyridone derivative that has been introduced for the treatment of CHF . Its mechanism of action involves inhibition of PDE3 leading to elevation of cAMP increasing the entry of Ca⁺⁺ ions into the cardiac tissues and hence increasing the contractility of the cardiac muscle | ||
| 700 | 0 |
_aAshraf H. Abadi , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c42368 _d42368 |
||